Cargando…

Proteome Analysis of Aflibercept Intervention in Experimental Central Retinal Vein Occlusion

Aflibercept is a frequently used inhibitor of vascular endothelial growth factor (VEGF) in the treatment of macular edema following central retinal vein occlusion (CRVO). Retinal proteome changes following aflibercept intervention in CRVO remain largely unstudied. Studying proteomic changes of aflib...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cehofski, Lasse Jørgensen, Kruse, Anders, Alsing, Alexander Nørgaard, Sejergaard, Benn Falch, Nielsen, Jonas Ellegaard, Schlosser, Anders, Sorensen, Grith Lykke, Grauslund, Jakob, Honoré, Bent, Vorum, Henrik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9182497/ https://www.ncbi.nlm.nih.gov/pubmed/35684299 http://dx.doi.org/10.3390/molecules27113360

Ejemplares similares

Dexamethasone Intravitreal Implant Is Active at the Molecular Level Eight Weeks after Implantation in Experimental Central Retinal Vein Occlusion
por: Cehofski, Lasse Jørgensen, et al.
Publicado: (2022)

Aflibercept Intervention in Experimental Branch Retinal Vein Occlusion Results in Upregulation of DnaJ Homolog Subfamily C Member 17
por: Cehofski, Lasse Jørgensen, et al.
Publicado: (2021)

Large-Scale Protein Analysis of Experimental Retinal Artery Occlusion
por: Vestergaard, Nanna, et al.
Publicado: (2023)

Intravitreal bevacizumab upregulates transthyretin in experimental branch retinal vein occlusion
por: Cehofski, Lasse Jørgensen, et al.
Publicado: (2018)

IL-18 and S100A12 Are Upregulated in Experimental Central Retinal Vein Occlusion
por: Cehofski, Lasse Jørgensen, et al.
Publicado: (2018)

Proteome Analysis of Bevacizumab Intervention in Experimental Central Retinal Vein Occlusion
por: Cehofski, Lasse Jørgensen, et al.
Publicado: (2023)

Laser-Induced Porcine Model of Experimental Retinal Vein Occlusion: An Optimized Reproducible Approach
por: Mæng, Mads Odgaard, et al.
Publicado: (2023)

A Review: Proteomics in Retinal Artery Occlusion, Retinal Vein Occlusion, Diabetic Retinopathy and Acquired Macular Disorders
por: Cehofski, Lasse Jørgensen, et al.
Publicado: (2017)

Dye-Free Porcine Model of Experimental Branch Retinal Vein Occlusion: A Suitable Approach for Retinal Proteomics
por: Jørgensen Cehofski, Lasse, et al.
Publicado: (2015)

Macular Edema in Central Retinal Vein Occlusion Correlates With Aqueous Fibrinogen Alpha Chain
por: Cehofski, Lasse Jørgensen, et al.
Publicado: (2023)

Aqueous Fibronectin Correlates With Severity of Macular Edema and Visual Acuity in Patients With Branch Retinal Vein Occlusion: A Proteome Study
por: Cehofski, Lasse Jørgensen, et al.
Publicado: (2020)

Animal Models Used to Simulate Retinal Artery Occlusion: A Comprehensive Review
por: Vestergaard, Nanna, et al.
Publicado: (2019)

Navigated laser and aflibercept versus aflibercept monotherapy in treatment‐naïve branch retinal vein occlusion: A 12‐month randomized trial
por: Frederiksen, Katrine Hartmund, et al.
Publicado: (2022)

Meibomian Gland Dysfunction Is Associated with Low Levels of Immunoglobulin Chains and Cystatin-SN
por: Muttuvelu, Danson Vasanthan, et al.
Publicado: (2023)

Functional and structural efficacy of a novel combinational therapy of aflibercept and timely focal/grid photocoagulation in diabetic macular oedema: do clinical study results compare favourably with a standard‐of‐care treated real‐world population?
por: Jørgensen, Mathias M., et al.
Publicado: (2022)

Retinal arteriolar oxygen saturation predicts the need for intravitreal aflibercept in patients with diabetic macular oedema
por: Blindbæk, Søren Leer, et al.
Publicado: (2020)

Circadian, Week-to-Week, and Physical Exercise-Induced Variation of Serum Microfibrillar-Associated Protein 4
por: Sækmose, Susanne Gjørup, et al.
Publicado: (2021)

Bevacizumab versus ziv-aflibercept in branch retinal vein occlusion
por: Braimah, Imoro Z, et al.
Publicado: (2019)

Microfibrillar-associated protein 4 variation in symptomatic peripheral artery disease
por: Hemstra, Line Ea, et al.
Publicado: (2018)

Microfibrillar-Associated Protein 4: A Potential Biomarker for Screening for Liver Fibrosis in a Mixed Patient Cohort
por: Sækmose, Susanne Gjørup, et al.
Publicado: (2015)

Serum MFAP4, a novel potential biomarker for liver cirrhosis screening, correlates with transient elastography in NAFLD patients
por: Kanaan, Reine, et al.
Publicado: (2023)

Intravitreal ziv-aflibercept for macular edema following retinal vein occlusion
por: Paulose, Remya, et al.
Publicado: (2016)

Proteomics and Nucleotide Profiling as Tools for Biomarker and Drug Target Discovery
por: Honoré, Bent, et al.
Publicado: (2021)

Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients
por: Johansson, Sofie Lock, et al.
Publicado: (2019)

Management of macular edema due to central retinal vein occlusion – The role of aflibercept
por: Rhoades, William, et al.
Publicado: (2017)

Changes in choroidal structure following intravitreal aflibercept therapy for retinal vein occlusion
por: Mitamura, Yoshinori, et al.
Publicado: (2021)

Predictive value of retinal oximetry, optical coherence tomography angiography and microperimetry in patients with treatment-naïve branch retinal vein occlusion
por: Frederiksen, Katrine Hartmund, et al.
Publicado: (2023)

Systemic virus infection results in CD8 T cell recruitment to the retina in the absence of local virus infection
por: Paskeviciute, Egle, et al.
Publicado: (2023)

Aflibercept in macular edema secondary to retinal vein occlusion: A real life study
por: Ozkaya, Abdullah, et al.
Publicado: (2017)

One-year outcomes of ziv-aflibercept for macular edema in central retinal vein occlusion
por: Eldeeb, Mohab, et al.
Publicado: (2017)

Effects of Switching to Aflibercept in Treatment Resistant Macular Edema Secondary to Retinal Vein Occlusion
por: Spooner, Kimberly, et al.
Publicado: (2020)

Subfoveal Choroidal Thickness and Treatment Outcomes of Intravitreal Aflibercept for Branch Retinal Vein Occlusion
por: Sakanishi, Yoshihito, et al.
Publicado: (2021)

New individualized aflibercept treatment protocol for branch retinal vein occlusion with macular edema
por: Noma, Hidetaka, et al.
Publicado: (2023)

Identification and characterization of endonuclein binding proteins: evidence of modulatory effects on signal transduction and chaperone activity
por: Ludvigsen, Maja, et al.
Publicado: (2009)

Attempting to distinguish between endogenous and contaminating cytokeratins in a corneal proteomic study
por: Lyngholm, Mikkel, et al.
Publicado: (2011)

Ca(2+ )binding to complement-type repeat domains 5 and 6 from the low-density lipoprotein receptor-related protein
por: Andersen, Olav M, et al.
Publicado: (2003)

Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients
por: Mölleken, Christian, et al.
Publicado: (2019)

Cardiovascular morbidity and all-cause mortality in patients with retinal vein occlusion: a Danish nationwide cohort study
por: Frederiksen, Katrine Hartmund, et al.
Publicado: (2023)

Surfactant Protein D Deficiency Aggravates Cigarette Smoke-Induced Lung Inflammation by Upregulation of Ceramide Synthesis
por: Pilecki, Bartosz, et al.
Publicado: (2018)

Comparison of the Efficacy of Intravitreal Aflibercept and Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion
por: Wang, Jia-Kang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ogpr6rjtspi0ob62jelv1r0eds